Synbiotics use for preventing sepsis and necrotizing enterocolitis in very low birth weight neonates: a randomized

Ozge Serce Pehlevan1, Derya Benzer1, Tugba Gursoy2

  • 1Neonatology Unit, Zeynep Kamil Maternity and Children's Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.

Insights

This study found that synbiotics and lactoferrin did not reduce necrotizing enterocolitis (NEC) or sepsis in very low birth weight neonates. However, the incidence of all NEC stages was lower in the synbiotic group.

Area of Science:

  • Neonatal Medicine
  • Gastroenterology
  • Microbiome Research

Background:

  • Probiotics and prebiotics exert strain-specific effects.
  • Synbiotics, combining probiotics and prebiotics, may offer enhanced host benefits.
  • Investigating synbiotics with lactoferrin for neonatal care is warranted.

Purpose of the Study:

  • To evaluate the efficacy of synbiotics combined with oligosaccharides and lactoferrin.
  • To determine the impact on necrotizing enterocolitis (NEC) or sepsis development.
  • To assess outcomes in very low birth weight neonates.

Main Methods:

  • A randomized controlled trial was conducted.
  • Participants were neonates with gestational age ≤32 weeks and birth weight ≤1,500 g.
  • The study group received synbiotics and lactoferrin; the control group received placebo.

Main Results:

  • No significant difference in NEC stage ≥2 or death, or NEC stage ≥2 or sepsis between groups.
  • The incidence of all stages of NEC was significantly lower in the synbiotic group (1.9% vs. 10.6%).
  • Mean birth weight and gestational age were comparable between groups.

Conclusions:

  • Synbiotics and lactoferrin combination did not reduce NEC severity, sepsis, or mortality.
  • A potential protective effect against early-stage NEC was observed.
  • Further research is needed to clarify the role of synbiotics in neonatal care.
Abstract